The role of oxidative stress and antioxidant defenses in Buerger disease and atherosclerotic peripheral arterial occlusive disease

Annals of Vascular Surgery
C ArslanSeyma Denli

Abstract

The aim of this study was to determine the status and the role of oxidative stress and antioxidant defenses in patients with Buerger disease and atherosclerotic peripheral arterial occlusive disease (PAOD). Seventy-three subjects resembling each other in general characteristics were involved in the study: 21 with lower extremity PAOD (mean age 53.05 +/- 10.8 years, 17 men and four women), 22 with Buerger disease (mean age 38.59 +/- 6.4 years, 19 men and three women), and 30 healthy volunteers (mean age 38.59 +/- 6.4 years, 22 men and eight women). We measured the levels of plasma malondialdehyde (MDA), paraoxonase (PON1), protein carbonyls, arylesterase, nitric oxide (NO), serum oxidized low-density lipoprotein (ox-LDL) and MDA, glutathione (GSH), glutathione reductase (GSH-red), glutathione peroxidase (GSH-px), superoxide dismutase (SOD), and catalase (CAT) in erythrocytes. Plasma protein carbonyls, serum ox-LDL, and plasma and erythrocyte MDA were significantly high in the Buerger disease group compared to the PAOD and control groups (p < 0.001). Plasma PON1 levels and GSH and GSH-px levels in erythrocytes in the Buerger disease group were significantly low compared to the PAOD and control groups (p < 0.001). GSH-red, SOD, an...Continue Reading

References

Jan 1, 1978·Biochemical Pharmacology·Y Masuda, T Murano
Jan 1, 1978·Methods in Enzymology·J A Buege, S D Aust
Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
Mar 1, 1991·Pharmacology & Toxicology·N K Cortas, N W Wakid
Oct 1, 1989·American Journal of Obstetrics and Gynecology·C A HubelM K McLaughlin
Jan 1, 1971·British Journal of Haematology·J Stocks, T L Dormandy
Sep 17, 1994·Lancet·J L Witztum
Apr 1, 1994·Clinica Chimica Acta; International Journal of Clinical Chemistry·Y Sun, L W Oberley
Nov 1, 1996·European Journal of Clinical Investigation·I WybrańskaA Dembinńska-Kieć
May 23, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·O Traub, B C Berk
Nov 18, 1998·Current Opinion in Nephrology and Hypertension·C Kitiyakara, C S Wilcox
Apr 16, 2002·European Journal of Clinical Investigation·B MacknessM I Mackness
Apr 5, 2003·Drug News & Perspectives·Bradford C. BerkRyan Hoefen
Mar 24, 2004·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Seval AydinSafiye Kaya
Apr 4, 2008·Clinical and Experimental Medicine·Ufuk CakatayHafize Uzun
Jul 23, 2008·Perspectives in Vascular Surgery and Endovascular Therapy·Kimon Bekelis, Nicos Labropoulos

❮ Previous
Next ❯

Citations

May 21, 2015·International Journal of Molecular Sciences·Anna Hernández-AguileraJordi Camps
Dec 9, 2014·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Aluísio LimaAlexandre Silva
Jan 10, 2020·Environmental Science and Pollution Research International·Guanghua MaoLiuqing Yang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.